GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide | Glypressin® | N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin | Terlivaz® | Variquel®
terlipressin is an approved drug (UK (2001), FDA (2022))
Compound class:
Peptide
Comment: Terlipressin is a clinically used vasopressin analogue. Terlipressin is biotransformed to its active moiety, lysine vasopressin (LVP). It has vasoconstrictive, antihemorrhagic, and antidiuretic properties.
|
|
|||||||||||||||||
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. UK MHRA (2001) | US FDA (2022) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5114 | terlipressin |
Database Links ![]() |
|
| CAS Registry No. | 14636-12-5 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL2135460 |
| DrugBank Ligand | DB02638 |
| DrugCentral Ligand | 2967 |
| GtoPdb PubChem SID | 434122301 |
| PubChem CID | 72081 |
| Search Google for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |
| Search Google for chemicals with the same backbone | BENFXAYNYRLAIU |
| Search PubMed clinical trials | terlipressin |
| Search PubMed titles | terlipressin |
| Search PubMed titles/abstracts | terlipressin |
| UniChem Compound Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |